My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Opko Health, Inc. - Common Stock (NQ:OPK)

1.230 +0.020 (+1.65%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Opko Health, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

7 Insider Stocks to Buy as Execs Snap Them Up ↗

February 18, 2022

With equity prices soaring to record levels, many execs have cashed out. Here are the insider stocks where execs are cashing in.

Via InvestorPlace

Executives Buying These 5 Penny Stocks ↗

February 16, 2022

Although US stock futures traded slightly lower this morning, there were a few notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the...

Via Benzinga

10 Best Stocks to Buy for Your Income-Generating Portfolio ↗

January 28, 2022

These 10 stocks to buy provide you with a dividend-income ladder from 1% to 10% yields. And hopefully some capital appreciation as well

Via InvestorPlace

Mid-Afternoon Market Update: Nasdaq Down 250 Points; OPKO Health Shares Plunge ↗

January 24, 2022

Toward the end of trading Monday, the Dow traded down 1.84% to 33,636.46 while the NASDAQ fell 1.83% to 13,517.61. The S&P also fell, dropping, 1.98% to 4,310.71. The U.S. has...

Via Benzinga

Earnings Scheduled For October 28, 2021 ↗

October 28, 2021

Companies Reporting Before The Bell • LendingTree (NASDAQ:TREE) is estimated to report quarterly earnings at $0.57 per share on revenue of $292.63 million. •...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

January 25, 2022

On Tuesday, 88 companies set new 52-week lows. Interesting Highlights From Today's 52-Week Lows: Credit Suisse Group (NYSE:CS) was the largest, in terms of market cap...

Via Benzinga

Mid-Day Market Update: Dow Dips 1000 Points; Exterran Shares Jump ↗

January 24, 2022

Midway through trading Monday, the Dow traded down 3.09% to 33,205.52 while the NASDAQ fell 4.56% to 13,141.60. The S&P also fell, dropping, 3.82% to 4,230.05. The U.S. has...

Via Benzinga

65 Biggest Movers From Yesterday ↗

January 25, 2022

Gainers Exterran Corporation (NYSE: EXTN) shares surged 59.7% to close at $4.79 on Monday after the company said it would merge with Enerflex to create a premier integrated...

Via Benzinga

Pfizer Dives After FDA Rejects Its OPKO-Partnered Rare Disease Treatment ↗

January 24, 2022

Pfizer stock tumbled after the FDA rejected an OPKO-partnered drug.

Via Investor's Business Daily

54 Stocks Moving In Monday's Mid-Day Session ↗

January 24, 2022

Gainers Exterran Corporation (NYSE: EXTN) shares jumped 52.4% to $4.5720 after the company said it would merge with Enerflex to create a premier integrated global provider of...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 24, 2022

Gainers SAB Biotherapeutics (NASDAQ:SABS) stock moved upwards by 15.0% to $6.3 during Monday's pre-market session. The market value of their outstanding shares is at $...

Via Benzinga

Benzinga Pro's Top 5 Stocks To Watch For Monday, Jan. 24, 2022: UL, SNAP, OPK, M, IBM ↗

January 24, 2022

Today's 5 Stock Ideas: Unilever (UL) - Shares rose following a media report that hedge fund Trian Partners has built a stake in the company. Snap (SNAP) - Wedbush...

Via Benzinga

28 Stocks Moving in Monday's Pre-Market Session ↗

January 24, 2022

Gainers BT Brands, Inc. (NASDAQ: BTBD) shares rose 158% to $6.37 in pre-market trading after declining around 12% on Friday. Kohl's Corporation (NYSE: KSS) rose 28.4% to $60...

Via Benzinga

A Peek Into The Markets: US Stock Futures Down Following Friday's Plunge ↗

January 24, 2022

Pre-open movers U.S. stock futures traded lower in early pre-market trade after the Dow Jones tumbled 450 points in the previous session. Investors are awaiting earnings results...

Via Benzinga

Pfizer - OPKO Health's Growth Hormone Deficiency Candidate Receives FDA Response Letter ↗

January 24, 2022

The FDA has issued a Complete Response Letter (CRL) to Pfizer Inc (NYSE: PFE) and OPKO Health Inc's (NASDAQ: OPK) somatrogon. Somatrogon...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 18, 2022

Gainers Brickell Biotech (NASDAQ:BBI) shares moved upwards by 71.1% to $0.36 during Tuesday's regular session. Brickell Biotech's stock is trading at a volume of...

Via Benzinga

Sema4 Strengthens AI-Driven Genomic, Clinical Data Platform With $623M GeneDx Acquisition ↗

January 18, 2022

Sema4 Holdings Corp (NASDAQ: SMFR) has agreed to acquire OPKO Health Inc's (NASDAQ: OPK) wholly-owned subsidiary, GeneDx Inc, for approximately $623...

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates ↗

December 31, 2021

Regulatory decisions by the U.S. Food and Drug Administration in December turned out to be mostly positive. Among the treatment options that were greenlighted in the month were...

Via Benzinga

Opko Health Posts Data From COVID-19 Trial With Its Kidney Disease Treatment ↗

December 23, 2021

OPKO Health Inc (NASDAQ: OPK) has announced preliminary topline results from its Phase 2 trial with Rayaldee to treat mild-to-moderate COVID-19. This study...

Via Benzinga

Bulls Find Silver Lining Into the Close ↗

December 20, 2021

While it isn't exactly a ringing endorsement that the market is heading higher, it is an indication that the Grinch hasn't entirely spoiled the fun.

Via Talk Markets

63 Biggest Movers From Friday ↗

December 20, 2021

Gainers Spruce Biosciences, Inc. (NASDAQ: SPRB) jumped 102.8% to close at $5.03 on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

December 17, 2021

Gainers Genfit (NASDAQ:GN...

Via Benzinga

28 Stocks Moving In Friday's Mid-Day Session ↗

December 17, 2021

Gainers Genfit SA (NASDAQ: GNFT) shares jumped 33.6% to $4.41 after the company, and Ipsen, announced an exclusive licensing agreement for elafibranor. X4 Pharmaceuticals, Inc...

Via Benzinga

OPKO Health Q3 Earnings Ahead Of Expectations ↗

October 29, 2021

OPKO Health Inc (NASDAQ: OPK) reported Q3 revenues were down 10% Y/Y to $385.8 million, beating the consensus of $302.27 million. Revenue from diagnostic services...

Via Benzinga

Opko Health (OPK) Q3 2021 Earnings Call Transcript ↗

October 29, 2021

OPK earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 28, 2021

Gainers Bellerophon Therapeutics (NASDAQ:

Via Benzinga

This Growth Hormone Drug Could Be a Boost For Pfizer ↗

October 05, 2021

Pfizer and OPKO Health's human growth hormone drug, somatrogon, could be approved by the U.S. Food and Drug Administration next January.

Via The Motley Fool

Pfizer's Growth Hormone Candidate FDA Review Pushed By 3 Months ↗

September 27, 2021

Pfizer Inc's (NYSE: PFE) effort to defend its growth hormone franchise against a new, more convenient competitor has hit a snag. The FDA has pushed back...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

September 24, 2021

Gainers eFFECTOR Therapeutics (NASDAQ:

Via Benzinga

The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical ↗

August 31, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.